Axogen, Inc. (LT3)
XSTU
Real-time Data
06:00 AM
Day's Range
31.8652 wk Range
13.30Overview - LT3 - Axogen, Inc.
Key Statistics
Valuation
Enterprise Value
32.08M
P/E (Trailing)
‪-111.52‬
PEG Ratio
‪0.27‬
Price / Book
‪7.89‬
EV / EBITDA
‪38.83‬
Profitability
Gross Margin
‪72.67%‬
Profit Margin
‪74.31%‬
Operating Margin
‪-3.55%‬
Return on Assets
‪-7.08%‬
Return on Equity
‪-12.18%‬
Ownership
Shares Outstanding
53.17M
Price stats
50-Day Avg
‪39.37‬
200-Day Avg
‪33.29‬
Peers - LT3 - Axogen, Inc.
Peer Comparison
Compared with companies in Medical Devices listed on XSTU.
- LT3XSTUAxogen, Inc.+61.76%52-week change-111.53P/E (Trailing)‪74.31%‬Profit Margin
- PENXSTUPBF Energy Inc.+68.22%52-week change7.71P/E (Trailing)‪3.93%‬Profit Margin
- HQE1XSTUCytoSorbents Corporation+94.73%52-week change-2.28P/E (Trailing)‪71.47%‬Profit Margin
- NG2XSTUNeogen Corp.+60.50%52-week change-300.00P/E (Trailing)‪46.93%‬Profit Margin
- 51KBXSTUAVITA Medical, Inc.+55.59%52-week change-6.12P/E (Trailing)‪82.13%‬Profit Margin
- HAZXSTUHaemonetics Corporation+53.04%52-week change44.61P/E (Trailing)‪59.03%‬Profit Margin
- 6GJXSTUGlaukos Corp.+49.26%52-week change-41.16P/E (Trailing)‪55.72%‬Profit Margin
Profile Summary - LT3 - Axogen, Inc.
About
Axogen, Inc. is a medical technology company focused on peripheral nerve regeneration and repair. Axogen develops and commercializes surgical solutions used by surgeons and healthcare providers to address nerve injuries caused by trauma, procedures, or disease. Its current product portfolio includes nerve allografts,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
